Understand the symptoms, diagnosis, treatment & management of Polycythemia Vera.

Clinical trial results for novel Myelofibrosis treatments were updated at the 2019 Amer Soc Hematology meeting.

Momelotinib to begin clinical trial in individuals with Myelofibrosis

Idasanutlin is active in the treatment of PV and ET and is currently being evaluated in a global phase 2 trial.

Thalidomide - Jakafi Combination may be Effective for Treatment of Myelofibrosis Associated Low Blood Counts

Leading cancer centers create combined social community with MPNRF PV Reporter & Cancer Connect to support MPN patients

Dr. Ruben Mesa, Mays Cancer Center answered questions about the management of polycythemia vera and myelofibrosis.

Phase III clinical trial reveals Jakafi superior to controlling symptoms and outcomes for Polycythemia Vera.